Compare COHR & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COHR | BAX |
|---|---|---|
| Founded | 1971 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.9B | 9.4B |
| IPO Year | 1987 | N/A |
| Metric | COHR | BAX |
|---|---|---|
| Price | $182.50 | $18.60 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 10 |
| Target Price | ★ $144.54 | $25.67 |
| AVG Volume (30 Days) | 5.0M | ★ 8.3M |
| Earning Date | 11-05-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 0.22% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.76 | N/A |
| Revenue | $6,043,358,000.00 | ★ $11,023,000,000.00 |
| Revenue This Year | $17.38 | $5.20 |
| Revenue Next Year | $13.50 | $2.02 |
| P/E Ratio | $238.87 | ★ N/A |
| Revenue Growth | ★ 20.80 | 3.90 |
| 52 Week Low | $45.58 | $17.40 |
| 52 Week High | $188.36 | $37.74 |
| Indicator | COHR | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 72.40 | 43.20 |
| Support Level | $158.21 | $18.33 |
| Resistance Level | $172.58 | $19.17 |
| Average True Range (ATR) | 10.66 | 0.54 |
| MACD | 2.57 | 0.21 |
| Stochastic Oscillator | 88.52 | 63.23 |
Coherent Corp engaged in materials, networking, and lasers, is a vertically integrated manufacturing company that develops, manufactures, and markets engineered materials, optoelectronic components and devices, and lasers for use in the industrial, communications, electronics and instrumentation markets. The firm operates in three segments Networking, Materials, and Lasers Segment. It generates maximum revenue from Networking segment. The company geographically operates in North America. Europe, China, Japan and Rest of the world.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.